Clinical Trials
18 trialsNCT07320508 2026-05-12
EIC-SNACC
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT07522879 2026-05-12
MRG003-SACC
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT07162480 2026-05-04
Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05377996 2026-04-14
A Study of XMT-1660 in Participants With Solid Tumors
Mersana Therapeutics
Phase 1 Recruiting
NCT06891560 2026-03-20
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06118086 2026-02-18
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Remix Therapeutics
Phase 1/2 Recruiting
NCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
NCT06462183 2025-11-14
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Rgenta Therapeutics Inc
Phase 1 Recruiting
NCT04883671 2025-09-23
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06805825 2025-09-23
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Novelty Nobility, Inc.
Phase 1 Recruiting
NCT06805617 2025-07-29
I-MAC
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT05774899 2025-06-17
CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Dana-Farber Cancer Institute
Phase 1/2 Recruiting
NCT06781567 2025-03-14
HG146
HitGen Inc.
Phase 2 Recruiting
NCT05733910 2025-02-13
SIBACIRT
CNAO National Center of Oncological Hadrontherapy
Phase NA Recruiting
NCT04214366 2023-11-30
ACCO
Heidelberg University
Phase 2 Recruiting
NCT04974866 2023-03-29
Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma
Qingdao Central Hospital
Phase 2 Recruiting
NCT02838602 2021-09-02
ETOILE
Hospices Civils de Lyon
Phase NA Recruiting